Medical

Mentor licenses patent covering method for treating urinary incontinence

Published in Women's Health Weekly, June 17th, 2004

Mentor Corp. (MNT), a leading supplier of medical products in the United States and internationally, announced that it has signed a nonexclusive license agreement with C.R. Bard covering the transobturator approach described in Mentor's U.S. patent no. 6,638,211 B2.

The transobturator patent covers a novel method for treating urinary incontinence in women that avoids many of the risks associated with other approaches. Terms of the agreement were not disclosed.

"Our hope is that broader application of this technology will drive market adoption and that the millions of women who suffer from this condition will benefit from this revolutionary approach,"...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-06-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry